EVOLTRA Trademark

Trademark Overview

On Friday, March 11, 2005, a trademark application was filed for EVOLTRA with the United States Patent and Trademark Office. The USPTO has given the EVOLTRA trademark a serial number of 78585618. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 16, 2009. This trademark is owned by Bioenvision, Inc.. The EVOLTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer and autoimmune diseases
evoltra

General Information

Serial Number78585618
Word MarkEVOLTRA
Filing DateFriday, March 11, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 16, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 17, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENZYME CORPORATION
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameBioenvision, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameBioenvision, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Tuesday, February 17, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 16, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 15, 2008EXTENSION 2 GRANTED
Tuesday, July 8, 2008EXTENSION 2 FILED
Tuesday, July 8, 2008TEAS EXTENSION RECEIVED
Thursday, March 13, 2008EXTENSION 1 GRANTED
Thursday, January 17, 2008EXTENSION 1 FILED
Thursday, March 13, 2008REVIEW OF CORRESPONDENCE COMPLETE
Wednesday, March 5, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 7, 2008ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Thursday, January 17, 2008TEAS EXTENSION RECEIVED
Thursday, January 17, 2008APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 17, 2008TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 17, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 17, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 17, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Saturday, May 26, 2007OPPOSITION TERMINATED NO. 999999
Saturday, May 26, 2007OPPOSITION DISMISSED NO. 999999
Wednesday, March 7, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 16, 2006OPPOSITION INSTITUTED NO. 999999
Thursday, January 26, 2006EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 27, 2005PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2005NOTICE OF PUBLICATION
Wednesday, November 9, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 4, 2005ASSIGNED TO LIE
Friday, October 28, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 28, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 19, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 19, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 25, 2005NON-FINAL ACTION E-MAILED
Sunday, September 25, 2005NON-FINAL ACTION WRITTEN
Saturday, September 24, 2005ASSIGNED TO EXAMINER
Thursday, March 17, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

evoltra autoimmune diseases cancer treatment preparations pharmaceutical